Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant diclofenac for prevention of Graves' ophthalmopathy (aGO study)
2005-000832-26Phase 4Active
- Sponsor
- Department of Endocrinology
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of diclofenac in Graves' ophthalmopathy (TED) and Graves' disease, sponsored by Department of Endocrinology. Primary endpoints: Prevention of development of Graves' ophthalmopathy and Activity of Graves' ophthalmopathy at diagnosis. Started Mar 2005; status: active.
02
Drugs
diclofenac
03
Conditions
Graves' ophthalmopathy (TED)Graves' disease
Beyond the preview
Go deeper on 2005-000832-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000832-26.